MME and breast carcinoma: Recent studies have suggested that the immunophenotype with CD10 expression represents a myoepithelial feature, and CD10 is one of the useful markers to track stem cells in breast carcinomas, especially precursors to sarcomatoid metaplastic carcinomas [16].